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Abstract 
PEGylation, the covalent modification of proteins with polyethylene glycol, is an abundantly 
used technique to improve the pharmacokinetics of therapeutic proteins. The drawback with this 
methodology is that the covalently attached PEG can impede the biological activity (e.g. reduced 
receptor-binding capacity). Protein therapeutics with “disposable” PEG modifiers have potential 
advantages over the current technology. Here, we show that a protein-polymer “Medusa 
complex” is formed by the combination of a hexavalent lectin with a glycopolymer. Using NMR 
spectroscopy, small angle X-ray scattering (SAXS), size exclusion chromatography and native 
gel electrophoresis it was demonstrated that the fucose-binding lectin RSL and a fucose-capped 
polyethylene glycol (Fuc-PEG) form a multimeric assembly. All of the experimental methods 
provided evidence of noncovalent PEGylation with a concomitant increase in molecular mass 
and hydrodynamic radius. The affinity of the protein-polymer complex was determined by ITC 
and competition experiments to be in the µM range, suggesting that such systems have potential 
biomedical applications.  
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Introduction 
The modification of proteins with synthetic polymers is a powerful route to novel functionalized 
macromolecules with applications in biotechnology and medicine.1–7 PEGylation, the covalent 
attachment of polyethylene glycol, is a versatile means to increase a protein’s size, stability and 
solubility.2,8–11 The increased radius of protein-PEG conjugates leads to a reduction in renal 
filtration, which together with decreased immunogenicity can result in longer circulation half 
lives compared to the native protein.9,10 Such improvements in pharmacokinetics are crucial for 
the development of cost-effective and patient-friendly protein therapeutics. However, 
PEGylation can also interfere with the processes of molecular recognition and lead to reduced 
biological activity. Steric hindrance of the binding site by PEG can impede complex formation 
with the target receptor.9,10 This effect may be eliminated in poly(zwitterion)-based conjugates.4 
Furthermore, reversible PEGylation strategies have been developed that take advantage of slowly 
hydrolysable,12,13 light-sensitive14 or thiol-sensitive15 linkers to release the PEG component.  
With the growing demand for tunable protein-polymer macromolecules the focus of 
attention is shifting towards noncovalent conjugates.16–26 Examples include polymer conjugation 
via: co-factor reconstitution,16 the biotin-streptavidin complex,18 supramolecular complexation 
with cucurbituril,19 charge-charge20 and metal affinity21,24 interactions, as well as lectin-mediated 
complexation.25,27,28 The advantage of noncovalent systems is that temporal control of conjugate 
assembly and disassembly can be asserted by the presence of competitor molecules.19 In the 
context of protein therapeutics it is envisaged that the biologically-active ligand-receptor 
complex may act as a competitor to displace the lower affinity polymer interaction. Thus, the 
potential interference caused by covalently attached PEG chains will be minimised. Noncovalent 
PEGylation involves several challenges, the foremost being the control of the protein-polymer 
affinity which must be sufficiently high to enable the positive effects of PEGylation (i.e. 
increased circulation half life) and yet low enough to permit transient unbinding and competition 
by the host receptor (Kd ~nM-µM). Coupled to this challenge is the need for simple linker 
chemistries which are biocompatible, synthetically attractive and inexpensive.  
At this point we note that the study of noncovalent protein-PEG assemblies is not new. 
Early applications were focused on protein purification by phase separation in mixtures of 
dextran and dye-conjugated PEG.29–31 Figure 4 in reference 30 is startling in its originality and 
relevance to current developments.  
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Here, we have combined a fucose-binding lectin with a fucose-capped polyethylene 
glycol (Fuc-PEG) to produce a noncovalent protein-polymer “Medusa complex” (Figure 1). 
RSL, a hexavalent fucose-binding lectin from Ralstonia solanacearum, was chosen as the model 
protein for this study. RSL is a well-characterized ~29 kDa trimer with three intra-monomeric 
and three inter-monomeric binding sites for L-fucose and related sugars.32–35 Building on current 
developments in the structural characterization of PEGylated proteins,11,36 we have used TROSY 
NMR spectroscopy to demonstrate protein-polymer noncovalent conjugation via the fucose-
binding site. The formation of high molecular weight protein-polymer particles was confirmed 
by size exclusion chromatography (SEC), small angle X-ray scattering (SAXS) and 
electrophoresis experiments. SAXS analysis further revealed a core structure bearing six PEG 
tails with random coil conformations. Competition binding experiments demonstrated that the 
Fuc-PEG appendages could be displaced by methyl-α-L-fucoside (Me-fuc) but not by L-
galactose (L-gal). Together, these data indicate that reversible protein-polymer conjugates were 
formed from the combination of a carbohydrate binding protein and a sugar-functionalized 
polymer. This strategy of noncovalent PEGylation may benefit the development of lectin-
mediated drug delivery systems.37–39 
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Materials and Methods 
Materials. Methyl-α-L-fucoside (Me-fuc) and L-galactose (L-gal) were purchased from 
Carbosynth and Sigma, respectively. L-fucose-capped polyethylene glycol (Fuc-PEG) was 
synthesized via a copper catalyzed azide-alkyne cycloaddition40 (Supporting Information, 
Scheme S1). Alkyne terminated PEG (Alk-PEG) was prepared according to an adapted literature 
procedure,41 by using PEG monomethyl ether (~2 kDa, Sigma 202509) and propargyl bromide. 
The 1H NMR spectrum of Alk-PEG included peaks at 2.42 and 4.18 ppm, assigned to the alkyne 
proton and the adjacent CH2 protons, respectively (Figure S1). 2-azidoethyl α-L-fucose was 
synthesized as described.42 For the click reaction, stoichiometric amounts of Alk-PEG and 2-
azidoethyl α-L-fucose were combined in t-butanol/water (5:1) in the presence of copper sulfate 
(0.1 eq.) and sodium ascorbate (0.2 eq.) at 50 °C for 24 h (Figures S1 and S2). The product was 
purified by flash chromatography and formation of the triazole was confirmed by 1H NMR 
(Figure S2) and ATR-FTIR spectroscopy (Figure S3). 
 
Protein samples. RSL was  produced in E. coli BL21, transformed with the plasmid pET25rsl, 
and purified by mannose-affinity chromatography.32 The 15N-labeled protein was prepared as 
described recently.35 
 
Size exclusion chromatography. SEC was carried out at 21° C on an Äkta FPLC equipped with 
an XK 16/70 column (1.6 cm diameter, 65 cm bed-height) packed with Superdex 75 (GE 
Healthcare). Filtered, degassed buffer (20 mM KPi, 50 mM NaCl, pH 6.0) was used at a constant 
flow rate of 1.5 mL/min. The samples (800 µL) contained RSL (0.25 mM) with 12 eq. of Fuc-
PEG or Me-fuc. Sample elution was monitored at 280 nm.  
 
Electrophoretic characterization of noncovalent PEGylation. Native electrophoresis was 
performed using 5% polyacrylamide or 2% agarose gels (6.0 cm x 7.0 cm) in horizontal mode. 
The samples (15 µL) contained 100 µM RSL and up to 12 equivalents of Fuc-PEG. Acrylamide 
gels were run at a constant voltage of 150 V in Tris/Gly buffer at pH 8.3 for 30 min. Agarose 
gels were run at 100 V in 20 mM KPi at pH 6.0 for 20 min. Visualization of the protein 
migration was achieved with Coomassie staining and a flatbed scanner.  
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NMR characterization. 1H-15N TROSY-HSQC43,44 spectra were acquired at 303 K on an 
Agilent 600 MHz NMR spectrometer equipped with a HCN cold probe. The samples contained 
0.25 or 0.5 mM 15N-RSL in the sugar-free form or in the presence of 1-12 equivalents of Fuc-
PEG, methyl-α-L-fucoside or L-galactose. The buffer (20 mM potassium phosphate, 50 mM 
NaCl, pH 6.0) was identical for all samples. The data were processed in NMRPipe.45 Differences 
in chemical shifts (∆δ) between the sugar-free and -bound forms of RSL were measured in 
CCPN46 and the average perturbations were calculated as ∆δavg = {[∆δH
2 + (0.2 × ∆δN
2)]/2}½.35,47  
 
Isothermal titration calorimetry. Experiments were performed at 25° C using a Nano ITC (TA 
Instruments) and conditions similar to those previously published.32 Samples of protein (24 µM) 
and ligands (1-2 mM) were prepared in identical buffer (0.1 M Tris-HCl, pH 7.5). Ligand 
solutions were added in 30 injections of 3 µl at intervals of 3 min while stirring at 300 rpm. A 
control experiment was performed by injecting Fuc-PEG into buffer, which yielded negligible 
heats of dilution. The data analysis was performed in NanoAnalyze. 
 
SAXS characterization. Small-angle X-ray scattering experiments were performed at the ESRF 
BioSAXS beamline BM29 equipped with a Pilatus 1M detector (Dectris).48,49 RSL bound to Me-
fuc or to Fuc-PEG was characterized at four different protein concentrations (10, 5, 2 and 1 
mg/ml) using the automated sample changer.50 Data were collected also on a sample of the 
conjugate that was pre-treated via an online SEC at BM29.51 All of the samples were prepared in 
the same buffer, identical to that used for the NMR experiments. 55 (automated sample changer) 
or 100 (SEC) µl volumes were exposed to X-rays for 10 individual frames, each 1 second in 
duration. Individual frames were processed with the automatic processing pipeline52, to yield 
individual radially-averaged curves of normalized intensity versus scattering angle s = 4πsinθ/λ. 
Additional data reduction in EDNA utilized the automatic data processing tools of the EMBL-
Hamburg ATSAS package53,54 to combine timeframes (excluding any data points affected by 
radiation damage), yielding the average scattering curve for each exposure series. Matched 
buffer measurements taken before and after every sample were averaged and used for 
background subtraction. Merging of separate concentrations and further analysis were performed 
manually using the ATSAS package.55  
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The forward scattering I(0) and radius of gyration Rg were calculated from the Guinier 
approximation.56 The hydrated particle volume was computed using the Porod invariant57 and the 
maximum particle size Dmax was determined from the pair distribution function computed by 
GNOM58 in PRIMUS.59 An estimate of the molecular mass (MM) of each construct was made 
from the I(0), with the partial specific volumes of RSL and PEG taken as 0.74 and 0.83 cm3/g, 
respectively.60  Ab initio models were calculated using DAMMIF61 and then averaged, aligned 
and compared in DAMAVER.62 CRYSOL63 was used to calculate the scattering of RSL based 
on the crystal structure coordinates32 (PDB 2BT9). In CORAL, 6 x 22 dummy residues with 
random coil conformations (P1 symmetry) were added to account for the six Fuc-PEG chains. 
The assumption of 22 residues per Fuc-PEG was based on the molecular weight (~2.3 kDa) and 
Svergun’s demonstration that the electron density of PEG (~0.4 e/Å3) is comparable to that of 
protein.60 The averaged and filtered model was used to visualize the protein-polymer assembly 
and SUPCOMB64 was used to optimally orient the RSL crystal structure (with minimal spatial 
discrepancy) into the final model. Fits of the models to the experimental data were prepared in 
SAXSVIEW (http://saxsview.sourceforge.net). 
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Results and Discussion  
Biochemical characterization of RSL bound to Fuc-PEG. The formation of a noncovalent 
conjugate between RSL and Fuc-PEG was expected to yield a particle of ~50 % increased mass 
(compared to RSL, ~29 kDa). Assuming that all six sugar-binding sites are occupied by Fuc-
PEG (~2.3 kDa) the conjugate will have a mass of ~43 kDa.  
An initial characterization of the conjugate was performed by using size exclusion 
chromatography. RSL in the presence of 12 equivalents of Me-fuc (Kd ~0.6 µM
32) eluted at ~75 
mL (Figure S4). This elution volume was higher than expected (the ~31 kDa DNase eluted at 
~65 mL) and suggests that RSL interacted weakly with the Superdex resin. In the presence of 
Fuc-PEG, elution was observed at ~55 mL, which corresponds to proteins of ~66 kDa (as 
indicated by a BSA standard). This higher-than-expected mass is characteristic of PEGylated 
proteins as the random coil nature of PEG occupies a larger volume than a corresponding mass 
of folded protein.11,65,66 The peak at ~43 mL, corresponding to the void volume, suggested the 
presence of high molecular weight aggregates.67 
The conjugate was further characterized by native gel electrophoresis. Samples of sugar-
free RSL or RSL in the presence of Fuc-PEG were analysed in polyacrylamide or agarose gels 
(Figure 2). Consistent with the theoretical pI of ~6.5, RSL and the conjugate migrated towards 
the anode or cathode at pH 8.3 or pH 6.0, respectively. In the sugar-free form a diffuse protein 
band was observed. With increasing amounts of Fuc-PEG the migration distance was decreased. 
This observation suggests that noncovalent PEGylation produced larger particles that were more 
effectively retarded by the gel. 
 
NMR characterization. 15N-labelled RSL was titrated with µL aliquots of Fuc-PEG (10 mM 
stock) and monitored by 1H-15N TROSY-HSQC spectroscopy. The TROSY was necessary to 
improve spectral quality, consistent with the increased molecular mass and longer tumbling time 
of the conjugate (Figure S5 shows a comparison of the HSQC and TROSY-HSQC spectra of 
RSL bound to Fuc-PEG). The protein-polymer interaction was in slow-exchange on the NMR 
timescale consistent with an equilibrium dissociation constant in the micromolar range.35,47 
Considering the overall similarity of the spectra of RSL bound to Me-fuc and RSL bound to Fuc-
PEG (Figure S6) it was evident that the highly-stable RSL structure32 was unaltered by 
interaction with the polymer.  
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Figure 3 shows spectral regions of the superposed 1H-15N TROSY-HSQC of sugar-free 
RSL and RSL in the presence of Fuc-PEG or Me-fuc. Recently, we assigned the backbone 
resonances of RSL in the sugar-free form and in the presence of fucose-like sugars including 
Me-fuc.35  Numerous resonances assigned to backbone and tryptophan indole nuclei in the sugar-
binding sites had similar chemical shift perturbations (∆δ) in the presence of Fuc-PEG or Me-fuc 
(Figure 3C). The similar pattern of shifts for each ligand indicated that Fuc-PEG binds to RSL in 
a fashion similar to Me-fuc. Interestingly, only two backbone resonances showed substantially 
different ∆δ due to Fuc-PEG binding. The ∆δavg for Lys34 and Asn79 in the presence of Fuc-
PEG were >2 times larger than in the Me-fuc form (Figure 3C). Lys34 and Asn79 are 
structurally equivalent residues located in loops that flank the inter- and intra-monomeric sugar 
binding sites, respectively.32,35 The backbone N atom of these residues is within 7.8 Å of the 
methyl substituent of Me-fuc in the RSL crystal structure (PDB 2BT9).32 The large ∆δ observed 
for these resonances (relative to the Me-fuc data) is evidence that the bulky Fuc-PEG polymer 
interacts at these sites. Note that the adjacent residues (33, 35 and 78, 80) are glycines and no 
amide resonances were observed in the sugar-free35 or in the polymer-bound form.  
The ~50 % increase in molecular mass of the RSL conjugate was expected to result in 
increased line widths of the NMR signals. In the presence of Me-fuc the average 1HN resonance 
line width of RSL was 19.8 (±2.3) Hz. In the presence of 12 equivalents Fuc-PEG the majority of 
the resonances demonstrated increased line widths and the average was 28.6 (±4.1) Hz (Table 
S1). This line broadening indicates an increased rotational correlation time consistent with the 
higher molecular weight of the complex with Fuc-PEG. The average broadening increase of ~8 
Hz due to six PEG chains (each ~2 kDa) contrasts with the ~1 Hz broadening observed for a 
monoPEGylated protein with 5 kDa PEG.11 Considering the possible contribution of aggregation 
(Figure S4) to the NMR data, a sample of RSL and 12 equivalents of Fuc-PEG was analysed by 
TROSY NMR before and after purification by SEC. The pre- and post-SEC samples yielded 
similar NMR spectra and the average line width was 26.0 (±4.4) Hz for the purified complex. 
Therefore, it can be concluded that the observed line width changes were due to noncovalent 
PEGylation (rather than aggregation).  
To assess whether the PEG alone contributed to the observed chemical shift perturbations 
control experiments were performed using PEG 2000 (the starting material for the Fuc-PEG 
synthesis). There were no appreciable effects on the NMR spectrum of RSL (Figure S7) 
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indicating that PEG 2000 did not bind at this concentration (3 mM).68 This result confirmed that 
the L-fucose cap was necessary for interaction.  
Competition binding experiments were used to assess the binding affinity of RSL for 
Fuc-PEG. The pre-formed complex of 0.25 mM RSL in presence of 6 equivalents (1.5 mM) of 
Fuc-PEG was treated with 1.5 mM of Me-fuc or L-gal. Examination of the tryptophan indole 
resonances (Figure 4), which are excellent reporters of sugar binding,35 indicated that the Fuc-
PEG appendages were displaced by Me-fuc (Kd ~ 0.6 µM
32) but not by L-gal (Kd ~ 9.0 µM
32). 
The indole resonances of RSL bound to Fuc-PEG were shifted upon the addition of Me-fuc 
(compare Figure 3B). Interestingly, the structurally equivalent W31 and W76 had split 
resonances (Figure 4, blue contours) suggesting that the Fuc-PEG was not completely displaced. 
In contrast the spectrum of RSL bound to Fuc-PEG was completely unchanged by the addition of 
the weaker binding L-gal. These experiments proved the noncovalent / reversible nature of the 
interaction between RSL and Fuc-PEG. ITC was used to further characterize the complex of 
RSL with Fuc-PEG (Figure S8). The fit parameters matched previously published data for Me-
fuc,32,34 and the measured Kd (1.3 ±0.3 µM) was consistent with the results of the competition 
experiments. 
 
Small angle X-ray scattering. RSL samples, at a maximum concentration of ~10 mg/mL, bound 
to Me-fuc or Fuc-PEG were characterised by SAXS. Data collection was performed using both 
the automated sample changer and the online SEC at BM29. The online SEC was used to remove 
high molecular weight aggregates (>150 kDa, Figure S4) immediately prior to data collection. 
The molecular mass (MM), the radius of gyration (Rg), the maximum particle size (Dmax), and 
the volume (V) of RSL bound to Me-fuc were estimated at 27 ±3 kDa, 1.8 ±0.1 nm, 4.8 ±0.2 nm, 
and 42 nm3, respectively. These parameters coincide, within error, with those computed from the 
RSL crystal structure (PDB 2BT9). The predicted scattering curve (CRYSOL) from the crystal 
structure fits neatly to the experimental data (χ = 1.97, Figure 5). Ab initio models calculated in 
DAMMIF61 (with P1 or P6 symmetry, Figure 5) matched the crystal structure (Figure 6). All of 
these data confirmed that RSL is a trimer in solution.  
Samples of RSL bound to Fuc-PEG resulted in a significant change to the scattering 
pattern (Figure 5). The parameters MM, Rg, Dmax, and V increased to 42 ±5 kDa, 2.9 ±0.1 nm, 
10.0 ±0.2 nm, and 72 nm3, respectively, consistent with the formation of the protein-polymer 
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conjugate. The difference in molecular weight between RSL bound to Me-fuc and RSL bound to 
Fuc-PEG was ~15 kDa in agreement with the expected mass difference of 13.8 kDa. Ab initio 
models generated in DAMMIF61 had six, three or one elongated protrusions that fit the 
experimental data with χ = 3.5, 2.8 or 2.4 for P6, P3 and P1 symmetry, respectively. The fit and 
corresponding envelope for P6 are shown in Figures 5 and 6B. As the resolution of the ab initio 
modelling was insufficient to determine the locations of the PEG chains, constrained rigid body 
modelling was performed in CORAL.54 Chains of 22 dummy residues, based on Svergun’s 
approximation,60 were used to model the Fuc-PEG. The Fuc-PEG appendages were constrained 
to the known fucose-binding sites (at residues Trp31 and Trp76 of the inter- and intra-
monomeric binding sites).32,35 The resulting model gave good fits to the scattering data (χ = 2.4) 
and overlaid neatly with the P6 ab initio envelope (Figure 6B). Irrespective of the modelling 
strategy and in agreement with earlier studies11,60,69 the Fuc-PEG chains were observed to extend 
away from the protein core, rather than interact with the protein surface. Therefore, the SAXS 
data were consistent with the proposed “Medusa complex”.  
RSL and Fuc-PEG are an interesting model system in the context of the “grafting 
distance” (DG) and the Flory dimension (RF) of the polymer.
11,60 The fucose-binding sites in RSL 
have a hexagonal arrangement with an edge length of ~2 nm (distance between the methyl 
substituents in Me-fuc crystal structure, PDB 2bt9). PEG 2000 has a RF of ~3.5 nm, which is 
~1.7-fold the grafting distance (nearest neighbours). As DG < RF the tendency is for the PEG to 
adopt an extended “brush” conformation and thereby reduce steric interactions between the 
polymer chains. This model is well-represented by the SAXS data (Figure 6B). 
 
Conclusions 
We have demonstrated the possibility of noncovalent PEGylation in a protein-polymer conjugate 
based on the hexavalent lectin RSL and a fucose-capped PEG. A variety of biophysical 
techniques were used to characterize complex formation. By using NMR spectroscopy it was 
confirmed that the glycopolymer interacts with the fucose-binding sites of the protein. The 
chemical shift perturbation plot was consistent with previously obtained data for the binding of 
“fucose like” sugars.35 The increase in NMR line widths and the necessity of the TROSY pulse 
sequence were indicative of an increased molecular weight (slower tumbling time) of the 
conjugate. The Kd for Fuc-PEG binding was estimated at ~1.3 µM by ITC measurements and the 
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reversible nature of the complex was demonstrated by competition experiments. The Fuc-PEG 
appendages were displaced by the tighter binding Me-fuc (while the weaker binding L-gal had 
no effect). Small angle X-ray scattering was used to elucidate the structure of the conjugate. The 
scattering data were consistent with a protein-polymer “Medusa complex” in which the PEG 
chains were extended from the protein core. In terms of broader applications, noncovalent 
PEGylation could involve proteins with an engineered sugar-binding site and a glyco-PEG with 
appropriate sugar functionality and PEG size. Alternatively, glyco-PEGs could be used as 
modifiers in drug delivery systems where lectin-bioadhesives control recognition and 
targeting.37-39 
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Supporting Information  
Synthetic scheme and spectral characterisation of intermediates and Fuc-PEG; SEC of RSL 
bound to Fuc-PEG or Me-fuc; HSQC and TROSY-HSQC of RSL in ligand-free and -bound 
forms; Line-width analysis of RSL resonances; TROSY-HSQC of PEG 2000 control experiment; 
ITC data for RSL binding to Fuc-PEG. 
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Figures 
 
 
 
Figure 1. Simplified representations of (A) fucose-capped PEG (Fuc-PEG, see Scheme S1 for 
details) and (B) noncovalent PEGylation of RSL with Fuc-PEG (~2.3 kDa) to yield a protein-
polymer “Medusa complex”. Note that RSL is a hexavalent trimer with three intra-monomeric 
and three inter-monomeric sugar binding sites.32,35 
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Figure 2. Native gel electrophoresis, 5 % polyacrylamide (top) or 2 % agarose (bottom panel), of 
RSL in the sugar-free or polymer bound form. The equivalents of Fuc-PEG, the buffer pH and 
the electrode locations are indicated.  
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Figure 3. Spectral regions (A) and (B) from the overlaid 1H-15N TROSY-HSQC spectra of 
sugar-free RSL (black contours) and RSL bound to Fuc-PEG (red) or Me-fuc (blue). (C) Plot of 
the average chemical shift perturbations (∆δ avg) due to interaction of RSL with 12 eq. of Fuc-
PEG (red) or Me-fuc (blue). The Me-fuc data were reported previously.35  
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Figure 4. Spectral region from the overlaid TROSY-HSQC spectra of RSL in the presence of 6 
equivalents of Fuc-PEG (red) and after the addition of 6 equivalents of Me-fuc (top) or L-gal 
(bottom panel). 
  
  
Page 23 of 26
ACS Paragon Plus Environment
Biomacromolecules
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
24 
 
 
 
Figure 5. SAXS data and model fits for RSL bound to Me-fuc (lower curves) and RSL bound to 
Fuc-PEG (upper curves). 
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Figure 6. Top down and side views of the SAXS models of (A) RSL bound to Me-fuc and (B) 
RSL bound to Fuc-PEG. The models are colour-coded to match the fits in Figure 5. The 
DAMMIF models of RSL generated with P1 or P6 symmetry are coloured magenta and cyan, 
respectively. The DAMMIF (P6) or CORAL (PEG chains only) models of RSL bound to Fuc-
PEG are coloured green and blue, respectively.  
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